Deerfield Management Company
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Fixed Income (Debt and Bonds)
Stage Focus
Seed, Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, Canada, Hong Kong, Japan, Australia, Europe, Asia, Singapore, China, India, Brazil, Mexico, South Korea, Middle East, Chile, Argentina, Colombia, Taiwan, Africa, South America
Industries Focus
- Healthcare
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Healthcare Technology
- Health Services
- Medical Equipment
- Healthcare IT
- Healthcare Real Estate
- Healthcare Infrastructure
- Healthcare Supply Chain
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 1994
Deerfield Management Company is a private investment firm established in 1994, dedicated to advancing healthcare through investment, intelligence, and philanthropy. The firm manages over $15 billion in assets as of December 2024, supporting a diverse portfolio of more than 200 private and public investments across the healthcare industry. Their focus spans therapeutics, medical devices, diagnostics, digital health, and health services, encompassing all stages of company evolution from startup to mature enterprises.
The firm's approach is characterized by collaboration, intellectual curiosity, and pragmatism, leveraging decades of operational expertise to navigate the complex healthcare and financial industries. Deerfield offers flexible financing options tailored to meet the needs of entrepreneurs and corporate partners, and its infrastructure supports the development of compelling assets on behalf of or in partnership with strategic and corporate partners.
In addition to its investment activities, Deerfield is committed to philanthropy through the Deerfield Foundation, an employee-run organization that partners with numerous non-profit organizations worldwide to improve children's health. Funding for the Foundation is provided through employee contributions and directly from Deerfield's profits, reflecting the firm's dedication to making a positive impact on global health.
Requirements
- Companies in the healthcare sector at various stages of development
- Innovative solutions in therapeutics, medical devices, diagnostics, digital health, and health services
- Entrepreneurial teams seeking flexible financing options
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Aptinyx Inc.
- Aprea Therapeutics
- Arvinas
- Axovant Gene Therapies
- Biohaven Pharmaceutical Holding Company
- Black Diamond Therapeutics
- Cerevel Therapeutics
- CureVac
- Denali Therapeutics
- Eagle Pharmaceuticals
- Enanta Pharmaceuticals
- Fate Therapeutics
- G1 Therapeutics
- Gilead Sciences
- Horizon Therapeutics
- Imara Inc.
- Inovio Pharmaceuticals
- Kura Oncology
- Loxo Oncology
- Mersana Therapeutics
Claim this Investor
Are you an official representative of Deerfield Management Company?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim